News

General surgery residents test laparoscopic skills ahead of SAGES competition.

Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.

David DeNardo, PhD, alongside his research team in the Tumor Immunology Program at Washington University School of Medicine, is working to understand why responses to cancer immunotherapy vary among patients.

Blue Ridge rankings place Washington University among the nation’s highest surgery departments for research funding.

The combination of clinical expertise and focused research means patients experience highly tailored care, whether surgery is needed or not

Surgical oncologist Trang Nguyen, MD, joined KMOV to discuss the type of cancer that led to country superstar Toby Keith’s death.

Last year across the country, just 658 out of 10,660 — 6% — of liver transplants came from living donors, federal data shows. But the number of living liver donors has been growing steadily over the past 10 years as the safety of donation improves and the waiting list for transplants grows.

Analyzing rates by age, race, tumor characteristics could inform prevention strategies

Urologist-scientist Henry Lai, MD, will lead national efforts to advance research in urologic diseases as chair of the AUA Office of Research.

Congratulations to the 51 faculty from the Department of Surgery who were recognized in the 2024 Castle Connolly Top Doctors list. 

A research team, including Ryan Fields, MD, has received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance, for a immunotherapy trial for melanoma.

Research projects will benefit from $1.5 million in new grants announced by Siteman Cancer Center.